This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations in Vaccine Development by Matthew Ryan Miezeiewski
Introduction
Matthew Ryan Miezeiewski is an accomplished inventor based in Phoenixville, PA (US). He has made significant contributions to the field of vaccine development, particularly in combating infections caused by clostridium difficile. His innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Miezeiewski holds a patent for "Vaccines against clostridium difficile comprising recombinant toxins." This invention focuses on recombinant toxin A (TcdA) and toxin B (TcdB), as well as binary toxin A (CDTa) proteins that have been specifically mutated to reduce or eliminate toxicity. The patent outlines vaccines and immunogenic compositions that utilize these recombinant toxins, providing protection against infections and their effects. Additionally, it describes methods for inducing an immune response through the administration of these vaccines and immunogenic compositions. The invention also includes methods for expressing the recombinant toxins in various expression systems, such as the baculovirus/insect cell expression system.
Career Highlights
Miezeiewski is associated with Merck Sharp & Dohme Corp., a leading pharmaceutical company known for its commitment to research and development in healthcare. His work at Merck has allowed him to contribute to groundbreaking advancements in vaccine technology.
Collaborations
Throughout his career, Miezeiewski has collaborated with notable colleagues, including Jon Henry Heinrichs and Jean-Luc Bodmer. These partnerships have fostered an environment of innovation and have been instrumental in the development of his patented technologies.
Conclusion
Matthew Ryan Miezeiewski's contributions to vaccine development exemplify the impact of innovative thinking in addressing public health challenges. His patent for vaccines against clostridium difficile showcases his dedication to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile